Synthesis and anticancer activity of chalcogenide derivatives and platinum(II) and palladium(II) complexes derived from a polar ferrocene phosphanyl-carboxamide

Applied Organometallic Chemistry

Volumn 24, Issue 5, 2010, Pages 392-397

  Schulz, Jiří ^a   Renfrew, Anna K ^b   Císǎrová, Ivana ^a   Dyson, Paul J ^b   Štěpnička, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b EPFL   (Switzerland)

Author keywords

Anticancer properties; Complexes; Ferrocene; Phosphanyl carboxamides; X ray crystallography

Indexed keywords

ANTICANCER ACTIVITIES; ANTICANCER PROPERTIES; BIOLOGICAL ACTIVITIES; CARBAMOYL; CARBOXAMIDES; CIS ISOMERS; ELEMENTAL SULFUR; FERROCENES; IN-VITRO; ORDER OF MAGNITUDE; OVARIAN CANCER CELLS; PALLADIUM COMPLEXES; PALLADIUM PRECURSORS; PHOSPHANES;

HYDROGEN PEROXIDE; HYDROGEN SULFIDE; IRON COMPOUNDS; MINERALOGY; PALLADIUM; PLATINUM; PLATINUM COMPOUNDS; SELF ASSEMBLY; STEREOCHEMISTRY; SULFUR; X RAY CRYSTALLOGRAPHY;

PALLADIUM COMPOUNDS;

EID: 77950951374     PISSN: 02682605     EISSN: 10990739     Source Type: Journal    
DOI: 10.1002/aoc.1626     Document Type: Article

References (63)

1. G. Giaccone, Drugs 2000, 59, 9.
2. M. A. Fuertes, C. Alonso, J.M. Perez, Chem. Rev. 2003, 103, 645.
3. L. R. Kelland, G. Abel, M. J. Mckeage, M. Jones, P. M. Goddard, M. Valenti, B. A. Murrer, K. R. Harrap, Cancer Res. 1993, 53, 2581.
4. M. A. Jakupec, M. Galanski, B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1.
5. W. H. Ang, S. Pilet, R. Scopelliti, F. Bussy, L. Juillerat-Jeanneret, P. J. Dyson, J. Med. Chem. 2005, 48, 8060.
6. T. Boulikas, Oncol. Rep. 2004, 12, 3.
7. S. Dhar, F. X. Gu, R. Langer, O. C. Farokhzad, S. J. Lippard, Proc. Natl Acad. Sci. USA 2008, 105, 17356.
8. W. H. Ang, I. Khalaila, C. S. Allardyce, L. Juillerat-Jeanneret, P. J. Dyson, J. Am. Chem. Soc. 2005, 127, 1382.
9. Selected examples: a) S. Urig, K. Fritz-Wolf, R. Reau, C. Herold-Mende, K. Toth, E. Davioud-Charvet, K. Becker, Angew. Chem. Int. Ed. 2006, 45, 1881.
10. T.W. Failes, C. Cullinane, C. I. Diakos, N. Yamamoto, J. G. Lyons, T.W. Hambley, Chem. Eur. J. 2007, 13, 2974.
11. H. Weber, J. Claffey, M. Hogan, C. Pampillon, M. Tacke, Toxicol. in Vitro 2008, 22, 531.
12. E. Alessio, G. Mestroni, A. Bergamo, G. Sava, Curr. Top. Med. Chem. 2004, 4, 1525.
13. C. G. Hartinger, S. Hann, G. Koellensperger, M. Sulyok, M. Groessl, A. R. Timerbaev, A. V. Rudnev, G. Stingeder, B. K. Keppler, Int. J. Clin. Pharmacol. Ther. 2005, 43, 583.
14. C. Scolaro, A. Bergamo, L. Brescacin, R. Delfino, M. Cocchietto, G. Laurenczy, T. J. Geldbach, G. Sava, P. J.Dyson, J.Med. Chem. 2005, 48, 4161.
15. L. Meca, D. Dvořák, J. Ludvík, I. Císařová, P. Štěpnička, Organometallics 2004,23, 2541.
16. P. Štěpnička, J. Schulz, I. Císař ová, K. Fejfarová, Collect. Czech. Chem. Commun. 2007, 72, 453.
17. M. Lamač, I. Císařov́a, P. Štěpnička, Eur. J. Inorg. Chem. 2007, 2274.
18. J. K uhnert, M. Dušek, J. Demel, H. Lang, P. ? Stěpnička, Dalton Trans. 2007, 2802.
19. M. Lamač, J. Tauchman, I. Císařov́a, P. Štěpnička, Organometallics 2007, 26, 5042.
20. J. K uhnert, M. Lamač, J. Demel, A. Nicolai, H. Lang, P. Štěpnička, J.Mol. Catal. A: Chem. 2008, 285, 41.
21. J. Kühnert, I. Císařov́a, M. Lamač, P. Štěpnička, Dalton Trans. 2008 2454.
22. J. Tauchman, I. Císařov́a, P. Štepnič ka, Organometallics 2009, 28, 3288.
23. J. Schulz, I. Císařov́a, P. Ště pnička, J. Organomet. Chem. 2009, 694, 2519.
24. M. Lamač, I. Císařov́a, P. Štěpnička, New J. Chem.2009,33,1549.
25. P. Štěpnička, M. Krupa, M. Lamač, I. Císařová J. Organomet. Chem. 2009, 694, 2987.
26. For related references concerning phosphanylferrocene carboxamides, see: a) W. Zhang, T. Shimanuki, T. Kida, Y. Nakatsuji, I. Ikeda, J. Org. Chem. 1999, 64, 6247.
27. J. M. Longmire, B.Wang, X. J. Zhang, J. Am. Chem. Soc. 2002, 124, 13400.
28. S.-L. You, X.-L. Hou, L.-X. Dai, J. Organomet. Chem. 2001, 637-639, 762.
29. J. M. Longmire, B. Wang, X. Zhang, Tetrahedron Lett. 2000, 41, 5435.
30. S.-L. You, X.-L. Hou, L.-X. Dai, B.-X. Cao, J. Sun, Chem. Commun. 2000, 1933.
31. M. Tsukazaki, M. Tinkl, A. Roglans, B.J. Chapell, N. J. Taylor, V. Snieckus, J. Am. Chem. Soc. 1996, 118, 685.
32. H. Jendralla, E. Paulus, Synlett 1997, 471.
33. J. Podlaha, P. Štěpnička, J. Ludvík, I. Císařov́a, Organometallics 1996, 15, 543.
34. P. Štěpnička, Eur. J. Inorg. Chem. 2005, 3787.
35. J. Schulz, I. C?ařov́a, P. Štěpnička, J. Organomet. Chem. 2009, 694, 2519.
36. C. J. Swarts, T. G. Vosloo, S. J. Cronje, W. C. Du Plessis, C. E. J. Van Rensburg, C. E. Kreft, J. E. Van Lier, Anticancer Res. 2008, 28, 2781.
37. W. C. M. Duivenvoorden, Y. Liu, G. Schatte, H.-B. Kraatz, Inorg. Chim. Acta 2005, 358, 3183.
38. G. Jaouen, S. Top, A. Vessières, in Bioorganometallics (Ed. G. Jaouen), Wiley-VCH: Weinhein, 2005., p. 65.
39. M. Auzias, B. Therrien, G.S̈uss-Fink, P. Štěpnič ka, W. H. Ang, P. J. Dyson, Inorg. Chem. 2008, 47, 578.
40. B. Weber, A. Serafin, J.Michie, C. Van Rensburg, J. C. Swarts, L. Bohm, Anticancer Res. 2004, 24, 763.
41. J. Rajput, J. R. Moss, A. T. Hutton, D. T. Hendricks, C. E. Arendse, C. Imrie, J. Organomet. Chem. 2004, 689, 1553.
42. H.-O. Kalinowski, S. Berger, S. Braun, 13C-NMR-Spektroskopie, Thieme: Stuttgart, 1984, chapter 4.
43. F. R. Hartley, The Chemistry of Platinum and Palladium, Applied cience: London, 1973.
44. P. Štěpnička, J. Podlaha, R. Gyepes,M. Polášek, J. Organomet. Chem. 1998, 552, 293.
45. P. S. Pregosin, R. W. Kunz, in 31P and 13C NMrof Transition Metal Phosphane Complexes, NMR Basic Principles and Progress, Vol.16 (Eds.: P. Diehl, E. Fluck, R. Kosfeld), Springer: Berlin, 1979, Chapter E, p. 65 and references therein.
46. N. Metzler-Nolte, M. Salmain, in Ferrocenes: Ligands, Materials and Biomolecules (Ed.: P. Štěpnička), Wiley: Chichester, 2008, chapter 13, pp. 499-639.
47. G. R. Gale, J. A. Howle, A. B. Smith, Proc. Soc. Exp. Biol. Med. 1970, 135, 690.
48. M. J. Cleare, J. D. Hoeschele, Platinum Met. Rev. 1973, 17, 2.
49. V. Brabec, M. Leng, Proc. Natl Acad. Sci. USA 1993, 90, 5345.
50. K. R. Harrap, Cancer Res. 1995, 55, 2761.
51. G. Natile, M. Coluccia, Coord. Chem. Rev. 2001, 216, 383.
52. J. M. Perez, M. A. Fuertes, C. Alonso, C. Navarro-Ranninger, Crit. Rev. Oncol./Hematol. 2000, 35, 109.
53. P. M. Calvert, M. S. Highley, A. N. Hughes, E. R. Plummer, A. S. T. Azzabi, M.W. Verrill, M. G. Camboni, B. A. Verdie, M. Zuchetti, A. M. Robinson, J. Carmichael, A. H. Calvert, Clin. Cancer Res. 1999, 5, 3796.
54. M. Van Beusichem, N. Farrell, Inorg. Chem.1992, 31, 634.
55. N. Farrell, L. R. Kelland, J. D. Roberts, M. Van Beusichem, Cancer Res. 1992, 52, 5065.
56. J. Jawbry, I. Freikman, Y. Najajreh, J. M. Perez, D. Gibson, J. Inorg. Biochem. 2005, 99, 1983.
57. M. Ohmichi, J. Hayakawa, K. Tasaka, H. Kurachi, Y. Murata, Trends Pharmacol. Sci. 2005, 26, 113.
58. D. Drew, J. R. Doyle, Inorg. Synth. 1972, 13, 47.
59. Z. Otwinowski, W. Minor, HKL Denzo and Scalepack Program Package, Nonius BV, Delft. For a reference, see: Z. Otwinowski, W. Minor, Meth. Enzymol. 1997, 276, 307.
60. A. Altomare, M. C. Burla, M. Camalli, G. L. Cascarano, C. Giacovazzo, A. Guagliardi, A. G. G. Moliterni, G. Polidori, R. Spagna, J. Appl. Crystallogr. 1999, 32, 115.
61. G.M. Sheldrick, SHELXL97. Program for Crystal Structure Refinement from Diffraction Data, University of Göttingen, Göttingen, 1997.
62. A. L. Spek, Platon -a multipurpose crystallographic tool, Utrecht University, Utrecht, 2003 and updates. Available from: http://www.cryst.chem.uu. nl/platon/.
63. T. Mosmann, J. Immunol.Meth. 1983, 65, 55.